Form 4: DocuSign Director Sells Shares Under 10b5-1 Plan

DocuSign Director James A. Beer sold 450 shares of common stock for $81.28 per share under a pre-arranged 10b5-1 trading plan.

Summary

• James A. Beer, a Director at DocuSign, Inc. (DOCU), reported a sale of common stock.
• The transaction involved the disposition of 450 shares.
• The sale price was $81.28 per share.
• The transaction was executed on September 16, 2025.
• This sale was conducted pursuant to a Rule 10b5-1 trading plan.
• Following the transaction, James A. Beer directly owns 14,199 shares and indirectly owns 5,543 shares through a trust.

Sentiment

Score: 5

Explanation: The transaction is a pre-scheduled sale under a 10b5-1 plan, which is generally considered neutral as it is not based on new material non-public information and is often part of a director's personal financial planning.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled transaction rather than a reaction to immediate market conditions or new material non-public information.

Negatives

• A director selling shares, even under a 10b5-1 plan, could be perceived negatively by some investors, potentially raising questions about insider confidence, though the pre-planned nature mitigates this concern.

Future Outlook

This Form 4 filing, detailing an insider transaction, does not provide any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is specific to DocuSign and its director, James A. Beer, and does not inherently reflect broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: May interpret director sales differently; however, the 10b5-1 plan suggests a routine, pre-planned transaction rather than a signal of lack of confidence in the company's future.

Key Dates

Recommendation

The filing reports a routine, pre-scheduled sale of a relatively small number of shares by a director under a 10b5-1 plan. This type of transaction typically does not signal a change in the company's fundamentals or the director's long-term view, thus it does not warrant a change in investment recommendation based solely on this filing.

Keywords

DocuSign, DOCU, Insider Trading, Form 4, Director Sale, 10b5-1 Plan, Equity Transaction, James A. Beer